JY
GNOM icon

Jeff Yass’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Jeff Yass’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.32M Buy
40,763
+22,397
+122% +$1.07M ﹤0.01% 6141
2026
Q1 		$803K Buy
18,366
+9,157
+99% +$424K ﹤0.01% 8460
2025
Q4 		$419K Buy
+9,209
New +$408K ﹤0.01% 9204
2025
Q2 		– Sell
-13,273
Closed -$422K – 13041
2025
Q1 		$422K Buy
13,273
+4,966
+60% +$188K ﹤0.01% 9286
2024
Q4 		$323K Sell
8,307
-13,781
-62% -$579K ﹤0.01% 9671
2024
Q3 		$994K Sell
22,088
-7,995
-27% -$357K ﹤0.01% 6788
2024
Q2 		$1.26M Buy
30,083
+24,793
+469% +$1.04M ﹤0.01% 6045
2024
Q1 		$241K Sell
5,290
-2,198
-29% -$100K ﹤0.01% 10201
2023
Q4 		$346K Buy
+7,488
New +$305K ﹤0.01% 9527
2023
Q2 		– Sell
-15,454
Closed -$762K – 12463
2023
Q1 		$762K Buy
+15,454
New +$795K ﹤0.01% 7514
2022
Q4 		– Sell
-6,480
Closed -$325K – 12875
2022
Q3 		$325K Buy
+6,480
New +$366K ﹤0.01% 9589
2022
Q2 		– Sell
-11,600
Closed -$697K – 13271
2022
Q1 		$697K Buy
+11,600
New +$732K ﹤0.01% 8098
2021
Q4 		– Sell
-18,709
Closed -$1.67M – 13400
2021
Q3 		$1.67M Buy
18,709
+10,880
+139% +$1.02M ﹤0.01% 6234
2021
Q2 		$779K Sell
7,829
-18,417
-70% -$1.63M ﹤0.01% 8451
2021
Q1 		$2.36M Buy
26,246
+18,693
+247% +$1.85M ﹤0.01% 5519
2020
Q4 		$716K Sell
7,553
-3,265
-30% -$273K ﹤0.01% 7485
2020
Q3 		$778K Buy
+10,818
New +$775K ﹤0.01% 6722
2020
Q1 		– Sell
-8,965
Closed -$560K – 10482
2019
Q4 		$560K Buy
8,965
+3,151
+54% +$180K ﹤0.01% 6761
2019
Q3 		$291K Buy
+5,814
New +$328K ﹤0.01% 8356

Other funds holding GNOM

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return
SWP
Stratos Wealth Partners Beachwood, Ohio $9.93B AUM 28.91% 1-Year Est. Return
CFD
Creative Financial Designs Kokomo, Indiana $2.1B AUM 23.1% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
FIA
Foundations Investment Advisors Phoenix, Arizona $9.72B AUM 29.41% 1-Year Est. Return
SH
SLT Holdings Scottsdale, Arizona $160M AUM 52.3% 1-Year Est. Return

Jeff Yass's GNOM Position: Q2 2026 in Review

Jeff Yass increased its Global X Genomics & Biotechnology ETF (GNOM) stake by 122% in Q2 2026, buying an estimated $1.07M and bringing the position to 40,763 shares worth $2.32M. The position accounts for ﹤0.01% of the portfolio, ranked #6141.

Jeff Yass first reported a position in GNOM in Q3 2019 and has held it in 19 quarters since. The position peaked at $2.36M in Q1 2021. 48 funds tracked by Wall St. Rank hold GNOM as of Q2 2026.

  • Jeff Yass held 40,763 shares of Global X Genomics & Biotechnology ETF worth $2.32M as of Q2 2026.
  • Jeff Yass bought 22,397 Global X Genomics & Biotechnology ETF shares in Q2 2026, an estimated $1.07M.
  • Global X Genomics & Biotechnology ETF made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #6141 holding.
  • Jeff Yass first reported a position in Global X Genomics & Biotechnology ETF in Q3 2019 and has held it in 19 quarters since.
  • Jeff Yass's Global X Genomics & Biotechnology ETF position peaked at $2.36M in Q1 2021.
  • 48 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.